Viatris Inc (VTRS) stock
VTRSNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 6/309% below fair value
$20.45−0.29 (-1.40%)
Close on Nov 17, 2026Market cap $23.49BP/E –Yield 2.35%
Viatris operating cash flow
Operating cash flow is the cash the business generates from its day-to-day operations.
Viatris's operating cash flow for the twelve months ending Jun 30, 2026 was $2.33B, up 12.9% year over year. For fiscal 2025 it was $2.32B, up 0.6% from the year before. The highest annual figure on record is $3.02B in fiscal 2021.
Annual operating cash flow
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $2.32B | +0.6% |
| FY2024 | Dec 31, 2024 | $2.30B | -20.6% |
| FY2023 | Dec 31, 2023 | $2.90B | -3.3% |
| FY2022 | Dec 31, 2022 | $3.00B | -0.6% |
| FY2021 | Dec 31, 2021 | $3.02B | +144.9% |
| FY2020 | Dec 31, 2020 | $1.23B | -31.7% |
| FY2019 | Dec 31, 2019 | $1.80B | -23.0% |
| FY2018 | Dec 31, 2018 | $2.34B | – |
Quarterly operating cash flow
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | $381.80M | +73.8% |
| Q1 FY2026 | Mar 31, 2026 | $388.30M | -27.5% |
| Q4 FY2025 | Dec 31, 2025 | $815.80M | +69.0% |
| Q3 FY2025 | Sep 30, 2025 | $744.90M | -9.9% |
| Q2 FY2025 | Jun 30, 2025 | $219.70M | -42.0% |
| Q1 FY2025 | Mar 31, 2025 | $535.50M | -12.9% |
| Q4 FY2024 | Dec 31, 2024 | $482.70M | -15.1% |
| Q3 FY2024 | Sep 30, 2024 | $826.50M | -1.0% |
| Q2 FY2024 | Jun 30, 2024 | $379.10M | -27.8% |
| Q1 FY2024 | Mar 31, 2024 | $614.60M | -36.7% |
| Q4 FY2023 | Dec 31, 2023 | $568.50M | +200.8% |
| Q3 FY2023 | Sep 30, 2023 | $835.20M | -3.9% |
| Q2 FY2023 | Jun 30, 2023 | $525.10M | -34.6% |
| Q1 FY2023 | Mar 31, 2023 | $971.20M | -14.7% |
| Q4 FY2022 | Dec 31, 2022 | $189.00M | -63.9% |
| Q3 FY2022 | Sep 30, 2022 | $869.00M | -20.0% |
| Q2 FY2022 | Jun 30, 2022 | $802.50M | +43.5% |
| Q1 FY2022 | Mar 31, 2022 | $1.14B | +34.1% |
| Q4 FY2021 | Dec 31, 2021 | $523.10M | +1345.0% |
| Q3 FY2021 | Sep 30, 2021 | $1.09B | +106.8% |
| Q2 FY2021 | Jun 30, 2021 | $559.40M | +47.4% |
| Q1 FY2021 | Mar 31, 2021 | $848.80M | +191.6% |
| Q4 FY2020 | Dec 31, 2020 | $36.20M | – |
| Q3 FY2020 | Sep 30, 2020 | $525.00M | – |
| Q2 FY2020 | Jun 30, 2020 | $379.50M | – |
| Q1 FY2020 | Mar 31, 2020 | $291.10M | – |
See a number that looks wrong?